zepbound eli lilly news - Search News

FDA says Lilly weight loss drug shortage is over

Hosted on MSN · 1d

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The agency's decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.

USA Today · 8h

Eli Lilly to test weight loss drug Zepbound to treat addiction

Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?

The Wall Street Journal on MSN · 1d

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly said the Food and Drug Administration approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. The company said Zepbound, or tirzepatide, is the first and only prescription medicine for adults suffering from this condition.

Verywell Health on MSN7d

Zepbound Helps People Lose More Weight Than Wegovy, According to Eli Lilly Trial

Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

1don MSN

Novo Nordisk’s next-generation weight-loss drug matches Lilly’s Zepbound in major trial, but doesn’t surpass it

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

FDA says knockoff versions of Lilly obesity drug must come off the market

The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved ...

2d

This Is Huge News for Eli Lilly Investors

Eli Lilly just gave investors several reasons to cheer.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results